biospecimen__admin__batch_number	405.45.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	AB93134F-B8BB-46CF-B3AF-D27A315D43CC
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-WX-AA44-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-WX-AA44-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-WX-AA44-01A
biospecimen__bio__biospecimen_barcode_bottom	0167787958
biospecimen__bio__day_of_creation	06
biospecimen__bio__day_of_shipment	30
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	03
biospecimen__bio__month_of_shipment	04
biospecimen__bio__pathology_report_file_name	TCGA-WX-AA44.759F0B44-92DC-4E47-BA10-7B19C4272485.pdf
biospecimen__bio__plate_column	2
biospecimen__bio__plate_id	A39D
biospecimen__bio__plate_row	G
biospecimen__bio__quantity	2.21
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	13.00
biospecimen__bio__year_of_creation	2014
biospecimen__bio__year_of_shipment	2014
biospecimen__shared__bcr_patient_barcode	TCGA-WX-AA44
biospecimen__shared__patient_id	AA44
clinical__ablation__ablation_performed_indicator	NO
clinical__ablation__bcr_ablation_barcode	TCGA-WX-AA44-A70655
clinical__ablation__bcr_ablation_uuid	895DE754-2102-438F-9A1D-E4A8443D0344
clinical__ablation__days_to_embolization_performed	274
clinical__ablation__embolization_performed_indicator	YES
clinical__ablation__embolization_type	Radioembolization
clinical__ablation__embolizing_agent_utilized	Y-90 Sirsphere
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	5A9FFB0F-4391-4776-A228-0DE116B72D68
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.5
clinical__chol_lihc_shared__albumin_result_specified_value	4.4
clinical__chol_lihc_shared__albumin_result_upper_limit	5.0
clinical__chol_lihc_shared__bilirubin_lower_limit	0
clinical__chol_lihc_shared__bilirubin_upper_limit	0.5
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__creatinine_lower_level	0.5
clinical__chol_lihc_shared__creatinine_upper_limit	1.2
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	0.6
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	6
clinical__chol_lihc_shared__fetoprotein_outcome_value	48
clinical__chol_lihc_shared__fibrosis_ishak_score	6 - Established Cirrhosis
clinical__chol_lihc_shared__hist_hepato_carc_fact	Non-Alcoholic Fatty Liver Disease
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	0.9
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	1.2
clinical__chol_lihc_shared__platelet_result_lower_limit	150
clinical__chol_lihc_shared__platelet_result_upper_limit	350
clinical__chol_lihc_shared__prothrombin_time_result_value	0.9
clinical__chol_lihc_shared__specimen_collection_method_name	Other (specify)
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.20
clinical__chol_lihc_shared__vascular_tumor_cell_type	None
clinical__clin_shared__age_at_initial_pathologic_diagnosis	64
clinical__clin_shared__bcr_followup_barcode	TCGA-WX-AA44-F68251
clinical__clin_shared__bcr_followup_uuid	272E007E-5500-4BDF-A858-979649EDE0C6
clinical__clin_shared__day_of_form_completion	21
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	1
clinical__clin_shared__history_prior_surgery_type_other	LEFT LATERAL HEPATECTOMY
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	YES
clinical__clin_shared__measure_of_response	Partial Response
clinical__clin_shared__month_of_form_completion	3
clinical__clin_shared__person_neoplasm_cancer_status	WITH TUMOR
clinical__clin_shared__platelet_result_count	215
clinical__clin_shared__post_op_ablation_embolization_tx	YES
clinical__clin_shared__postoperative_rx_tx	YES
clinical__clin_shared__radiation_therapy	YES
clinical__clin_shared__relative_family_cancer_history	NO
clinical__clin_shared__residual_tumor	RX
clinical__clin_shared__tissue_prospective_collection_indicator	YES
clinical__clin_shared__tissue_retrospective_collection_indicator	NO
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__viral_hepatitis_serology	Hepatitis  C Antibody
clinical__clin_shared__year_of_form_completion	2012
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2011
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	None
clinical__lihc_nte__new_tumor_event_ablation_embo_tx	Yes
clinical__lihc_nte__new_tumor_event_liver_transplant	No
clinical__nte__additional_pharmaceutical_therapy	YES
clinical__nte__additional_radiation_therapy	YES
clinical__nte__days_to_new_tumor_event_after_initial_treatment	246
clinical__nte__new_neoplasm_event_occurrence_anatomic_site	Liver
clinical__nte__new_neoplasm_event_type	Intrahepatic Recurrence
clinical__rad__anatomic_treatment_site	Primary Tumor Field
clinical__rad__bcr_radiation_barcode	TCGA-WX-AA44-R70654
clinical__rad__bcr_radiation_uuid	23145CED-9A16-4516-9724-23CFB2C8E2A9
clinical__rad__days_to_radiation_therapy_end	357
clinical__rad__days_to_radiation_therapy_start	357
clinical__rad__numfractions	1
clinical__rad__radiation_dosage	0.29
clinical__rad__radiation_treatment_ongoing	NO
clinical__rad__radiation_type	Internal
clinical__rx__bcr_drug_barcode	TCGA-WX-AA44-D70641
clinical__rx__bcr_drug_uuid	CF571D27-7579-40DA-8545-E2A600A0CDA1
clinical__rx__days_to_drug_therapy_end	375
clinical__rx__days_to_drug_therapy_start	306
clinical__rx__drug_name	SORAFENIB
clinical__rx__therapy_ongoing	NO
clinical__rx__therapy_type	Targeted Molecular therapy
clinical__rx__tx_on_clinical_trial	NO
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G3
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	MX
clinical__shared_stage__pathologic_n	NX
clinical__shared_stage__pathologic_t	T1
clinical__shared_stage__system_version	7th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	8f0b105f-e2de-4433-bd6a-dd81cb6c0c93
gdc__aliquots__concentration	0.17
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-WX-AA44-01A-11R-A39D-07
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	e24b1dfa-054f-41b6-9130-ac5b60d15a1a,da4da348-c74f-410d-8378-7852f007076b,7be89d9e-f981-4103-831a-f473cb90306f
gdc__analysis__workflow_link	https://github.com/NCI-GDC/htseq-cwl
gdc__analysis__workflow_type	HTSeq - Counts,HTSeq - FPKM-UQ,HTSeq - FPKM
gdc__analysis__workflow_version	v1
gdc__analytes__a260_a280_ratio	1.83
gdc__analytes__analyte_id	af478561-b817-48b1-9005-62648ab8d578
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	5436fafb-bc16-4450-ac8b-568e1e5ee5fe
gdc__center__center_id	ee7a85b3-8177-5d60-a10c-51180eb9009c
gdc__center__center_type	CGCC
gdc__center__code	07
gdc__center__name	University of North Carolina
gdc__center__namespace	unc.edu
gdc__center__short_name	UNC
gdc__created_datetime	2016-05-29T10:29:37.566365-05:00,2016-05-29T10:29:37.758738-05:00,2016-05-29T10:29:37.961577-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	Gene Expression Quantification
gdc__demographic__demographic_id	73f2b5ba-e762-5551-b43d-0d47e8a16ef7
gdc__demographic__ethnicity	hispanic or latino
gdc__demographic__gender	female
gdc__demographic__race	white
gdc__demographic__year_of_birth	1947
gdc__diagnoses__age_at_diagnosis	23654
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-23654.0
gdc__diagnoses__days_to_last_follow_up	615.0
gdc__diagnoses__diagnosis_id	f7e5c78f-4e01-5acc-876d-14a91cf5fd89
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage i
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	RNA-Seq
gdc__exposures__bmi	26.40235457063712
gdc__exposures__exposure_id	f66c9ba1-8f10-5bd0-b93f-25acba06c4c4
gdc__exposures__height	152.0
gdc__exposures__weight	61.0
gdc__file_id	ce78734f-cafa-4fd8-9d22-836dc9c1830f,0a1fefb0-9977-4491-9276-b519e57b6fa2,d75e8818-81a3-4b25-9416-c649ea71083c
gdc__file_name	eea3fcee-ee51-461b-abb4-c393c084e018.htseq.counts.gz,eea3fcee-ee51-461b-abb4-c393c084e018.FPKM-UQ.txt.gz,eea3fcee-ee51-461b-abb4-c393c084e018.FPKM.txt.gz
gdc__file_size	244916,487981,486421
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	RNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	eb77112a7879d2c7e84146f9a97608e3,562858bd3432508efc649471df7589b4,684868bf35553d111e6530d419cfc284
gdc__portions__is_ffpe	false
gdc__portions__portion_id	8db861bd-49b0-4c08-b719-75563456456a
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	924
gdc__samples__initial_weight	90.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	759F0B44-92DC-4E47-BA10-7B19C4272485
gdc__samples__sample_id	faf5de3b-b8b2-43d9-89c4-1a6b2ee207a5
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	0.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	10.0
gdc__slides__percent_tumor_cells	90.0
gdc__slides__percent_tumor_nuclei	95.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	3692bcc2-f48e-4f98-9c78-b02127fdf5b0
gdc__submitter_id	eea3fcee-ee51-461b-abb4-c393c084e018_count,eea3fcee-ee51-461b-abb4-c393c084e018_uqfpkm,eea3fcee-ee51-461b-abb4-c393c084e018_fpkm
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	WX
gdc__tissue_source_site__name	Yale University
gdc__tissue_source_site__tissue_source_site_id	39c0854e-a35b-56ba-ae48-3d0f45b5c305
gdc__treatments__treatment_id	4f8dbc80-f7cd-53b1-b3bf-3e2193019723
gdc__type	gene_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T08:08:58.603+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/gene_expression_quantification/8f0b105f-e2de-4433-bd6a-dd81cb6c0c93-geq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/gene_expression_quantification/8f0b105f-e2de-4433-bd6a-dd81cb6c0c93-geq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	5033567
manually_curated__local_md5	5017a6a001e3335515405384ee2a4e0d
manually_curated__opengdc_download_date	2018-10-15T16:28:06.000908+02:00
manually_curated__opengdc_file_md5	aecb5f1ec8a020c5dfa309cb01da552d
manually_curated__opengdc_file_size	1637205
manually_curated__opengdc_id	8f0b105f-e2de-4433-bd6a-dd81cb6c0c93-geq
manually_curated__origin_file_size	5033567
manually_curated__origin_last_modified_date	Mon Oct 15 16:36:00 CEST 2018
manually_curated__origin_md5	5017a6a001e3335515405384ee2a4e0d
manually_curated__tissue_status	tumoral
num	60483
